本年度信息
根据公告,普华和顺集团预计截至2025年12月31日止年度的经调整净利润介乎1.20亿元至1.47亿元,相比2024年约1.925亿元同比下降38%至24%。其中,公司拥有人应占净利润预计为0.83亿元至1.02亿元,相比2024年约1.508亿元同比下降45%至32%。
业务分项
公告显示,上述利润下滑主要由输液器业务板块销售下降所致,原因在于相关集采政策几近全面施行,对业务造成明显影响。
本年度信息
根据公告,普华和顺集团预计截至2025年12月31日止年度的经调整净利润介乎1.20亿元至1.47亿元,相比2024年约1.925亿元同比下降38%至24%。其中,公司拥有人应占净利润预计为0.83亿元至1.02亿元,相比2024年约1.508亿元同比下降45%至32%。
业务分项
公告显示,上述利润下滑主要由输液器业务板块销售下降所致,原因在于相关集采政策几近全面施行,对业务造成明显影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.